2H 13C 15N enriched proteins
ready for NMR ready for crystallization
Our Products
Recombinant proteins (135) Isotopically enriched proteins (297) Proteins as NMR standard (41) Chemicals (30) Analytical standard (27) Antibodies (38) Biological kits (2) Molecular biology (35) Media & Ingredients (5) Electrophoresis (12) Blotting (5) Resins (2) Cell cultures & Transfection (3) Antibiotics (11) Synthetic PEPTIDES (38)List All Products |
|
|
Advanced Search |
Member Login
Peptides custom synthesis
bioactive peptides...labeled peptides...non-natural/modified peptides
Experience the NMR and X-ray services...
... DRUG/target 3D structure and characterization by NMR and X-ray
Best recombinant proteins...
... NMR & Mass verified, highly purified, fully active!
| Most recent publications |
|
Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schäfer H, Schütz B, Spraul M. Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1420-4. Arendt, Y., Bhaumik, A., Del Conte, R., Luchinat, C., Mori, M., and Porcu, M. Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites. ChemMedChem, 2007 Arendt Y, Banci L, Bertini I, Cantini F, Cozzi R, Del Conte R, Gonnelli L. Catalytic domain of MMP20 (Enamelysin) - the NMR structure of a new matrix metalloproteinase. FEBS Lett. 2007, 581(24):4723-6. Gieldon A., Mori M, Del Conte R. Theoretical study on binding of S100B protein. J. Mol. Model. 2007 Assfalg M, Bertini I, Del Conte R, Giachetti A, Turano P. Cytochrome c and organic molecules: solution structure of the p-aminophenol adduct. Biochemistry. 2007 May 29;46(21):6232-8. Epub 2007 May 9. Bertini I, Calderone V, Fragai M, Giachetti A, Loconte M, Luchinat C, Maletta M, Nativi C, Yeo KJ. Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases. J Am Chem Soc. 2007, 129(9):2466-75. Bertini I., Grassi E., Luchinat C., Quattrone A., Saccenti E. Monomorphism of human cytochrome c. Genomics 2006, 88 (5), 669-672 Calderone V., Fragai M., Luchinat C., Nativi C., Richichi B., Roelens S. A high-affinity carbohydrate-containing inhibitor of matrix metalloproteinases. Chem. Med. Chem. 2006, 1 (6), 598-601 Bertini I., Fragai M., Giachetti A., Luchinat C., Maletta M., Parigi G., Joo Yeo K. Combining in silico tools and NMR data to validate protein-ligand structural models: application to matrix metalloproteinases. J. Med. Chem. 2005, 48 (24), 7544-59. Fragai M., Nativi C., Richichi B., Venturi C. Design In Silico, Synthesis and Binding Evaluation of a Carbohydrate-Based Scaffold for Structurally Novel Inhibitors of Matrix Metalloproteinases. ChemBioChem. 2005, 6, 8, 1345-9 Andreini C., Banci L., Bertini I., Luchinat C., Rosato A. A bioinformatic comparison of structures and homology-models of matrix metalloproteinases. J. Proteome Res. 2004, 3:21-31 Bertini I., Fragai, M., Lee, Y.-M., Luchinat, C., and Terni, B. Paramagnetic metal ions in ligand screening: the Co(II) matrix metalloproteinase 12. Angew. Chem. Int. Ed Engl. 2004 Apr 19;43(17):2254-6 Bertini I., Calderone V., Fragai M., Luchinat C., Mangani S., Terni B. Crystal structure of the Catalytic domain of Human Matrix Metalloproteinase 10. J. Mol. Biol. 2004, 336(3):707-16 |
